BCLS Acquisition Corp.

BCLS Acquisition Corp. (Nasdaq: BLSA) is a special purpose acquisition company sponsored by Bain Capital Life Sciences, the dedicated healthcare-focused investment arm of Bain Capital. The company priced its initial public offering in 2021 and targets businesses operating in the biopharmaceutical, medical technology, and broader life sciences sectors. The Form 10-Q filed May 12, 2022 covers the company's operations during its target-search period, reflecting BLSA's status as a blank-check vehicle actively evaluating acquisition candidates. The sponsor's established presence in healthcare investing informs the company's sector mandate. For complete filing history, status tracking, and real-time SPAC analytics on BLSA, sign up for full data access at SpacDesk.